Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bausch & Lomb revamped eye drop line ads start, survey results announced.

This article was originally published in The Tan Sheet

Executive Summary

EYE DROP REDNESS RELIEVER FOR BURNING EYES CHOSEN BY TWO-THIRDS OF CONSUMERS but only 3% of optometrists in a survey commissioned by Bausch & Lomb. The two-phase telephone survey, which involved 1,017 consumers age 18 and older selected through random digit dialing and 100 optometrists from around the U.S., was conducted to measure potential misuse of OTC eye drops to treat specific eye irritations. Decision Research, Inc., a Cincinnati-based market research firm, conducted the survey.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088172

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel